THE HITCHHIKER’S GUIDE TO THE GLOBAL FUND (AND USG ENGAGEMENT WITH THE GLOBAL FUND)

Today’s Objectives: You’ll get to know… 1.The basics of the Global Fund to fight AIDS, TB and malaria 2.How the USG engages with the Global Fund 3.How the USG provides Technical Assistance for Global Fund grants

Global Fund -- Founding Principles The Global Fund is a financing mechanism, not an implementing mechanism for country-led efforts to combat HIV/AIDS, tuberculosis, and malaria. Public-private partnership Can be accessed by all affected countries The Global Fund evaluates proposals through independent review processes based on technical merit. Scale – aims to expand successful interventions

Global Fund structures Board Secretariat TRP OIG LFA Proposal Grant Agreement Sub Agree- ments CCM PRPR SR SSR PRPR SR SSR

The Board: Issues call for proposals CCM: Coordinates proposal development and submission Secretariat: Screens for eligibility Technical Review Panel: Reviews and recommends for funding The Board: Approves funding for the first two years Principal Recipient: Signs grant, sets targets, implements Global Fund Proposals – The Process

Global Fund grants cover a 5-year period 2 Phases: Phase I – two years, Phase II – next 3 years Before end of Phase I – PR must submit a Request for Continued (Phase II) Funding Phase II request reviewed by LFA, CCM, Secretariat Secretariat recommendation on Phase II funding goes to Board for approval Global Fund Grant – Lifespan

Performance-Based Funding Grant recipients report regularly on results & expenditures (quarterly or semi-annually) Local Fund Agents (LFAs) verify reported results & expenditures Performance evaluated and rated at every progress update Performance influences disbursement & future funding decisions Conditions Precedent (CPs) to disbursement Corrective actions for poor performance – Time Bound Actions (TBA) or Suspensions

Nine rounds of grant-making to date (Review of Round 10 is underway) 780 Grants 144 countries for $19.4 billion $11.6 billion disbursed to date

Portfolio breakdown by disease

Key Results to September 2010 Source: The Global Fund

USG ENGAGEMENT

Global Fund – Top 10 Donors to Date 1.United States $5.1 billion 2.France $2.187 billion 3.Japan $1.288 billion 4. European Commission $1.204 billion 5. Germany $1.185 billion 6. United Kingdom $1.177 billion 7. Italy $1.008 billion 8. Canada $844 million 9. Gates Foundation $650 million 10. Spain $583 million

Global Fund Structures Board Secretariat TRP OIG LFA Proposal Grant Agreement Sub Agree- ments CCM PRPR SR SSR PRPR SR SSR

USG TECHNICAL ASSISTANCE

USG-funded Technical Assistance (TA) Congress authorized Global AIDS Coordinator to withhold up to 5% of Global Fund appropriations for Global Fund TA TA for Grant signature and implementation issues (not proposal development) TA for disease-specific technical assistance and for management issues Short-term (bottleneck removal) Demand-driven (CCMs, PRs, and sub-recipients)

USG TA Portfolio Disease Specific TA –Malaria (Malaria Action Committee, RBM) –TB (STOPTB and the Green Light Committee) –HIV/AIDS (UNAIDS Secretariat and TSFs) TA for Management issues –Grant Management Solutions (GMS) project –The US Global Fund Liaisons -$94.7 million approved to date (since FY 2005)

Global Fund Liaisons Round 1 (FY 2007) –DRC – Eteni Longondo –Indonesia – Jeff Muschell –Malawi –Mozambique – Chantal Auger –West Africa (regional) – Fatimata Sy –Haiti Round 2 (FY 2008) –Cambodia –East Africa (regional) –Zimbabwe –Central America (regional) –Central Asia (regional) –South Sudan –India

Grant Management Solutions (GMS) USAID Contract with MSH (managed from OGAC) Urgent, short-term technical support to CCMs & grants to unblock bottlenecks & systemic problems hindering performance, assist CCMs & PRs to meet GF conditions precedent & deadlines Build capacity of CSOs to participate Focus on 4 areas of TA: –CCM governance and leadership –PR program and financial management –Procurement and Supply Management (PSM) –Monitoring and evaluation (M&E)

The GMS approach Participative Offering multiple options Facilitating decision making by CCMs and PRs Assisting PRs to meet GF deadlines Measuring success by GF performance markers

LACE. Europe & Middle East Anglophone Africa Franco/Luso AfricaAsia, SW Asia COPRECOS (1) Honduras (3) Guatemala Mexico (6) Nicaragua (2) Peru (2) Albania (2) Armenia (5) Djibouti Jordan Kazakhstan Kyrgyz Rep. Mauritania (4) Morocco (3) Niger Serbia Tunisia Ukraine Yemen Ghana (2) Lesotho Liberia Namibia (3) Nigeria (4) Sierra Leone (5) Southern Sudan Swaziland (3) West Africa Corridor (5 countries) Zambia Zimbabwe (3) Angola (2) Burundi Cameroun (3) Central African Republic (7) Comoros (2) Cote d’Ivoire (3) Democratic Republic of Congo (8) Guinea Madagascar Mali Mozambique (3) Rep of Congo Sao Tome y Principe Senegal (4) Togo Afghanistan (3) Bangladesh (2) Bhutan (4) Cambodia (2) East Timor Fiji (3) India (4) Indonesia (5) Laos PDR (2) Mongolia Nepal (6) Pakistan (6) Papua New Guinea Philippines (5) GMS Countries to date GMS work has affected 237 grants (27% of all grants) worth $3.07 billion (26.4% of all funds approved to date)

GMS Results Outcome As of August 31, 2010 # of new grants signed15 # of Phase II and RCC signed10 Total value of grants and phases signed with GMS assistance $ 514 million # of grants for which dashboard was developed for CCM oversight 32 # of Conditions Precedent met after GMS 57

Pearls: Primary Global Fund Principle - Performance-based Funding

Where to go to get more info…

THE END